Related Experiment Video
Updated: Sep 17, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.3K
GAN-enhanced deep learning for improved Alzheimer's disease classification and longitudinal brain change analysis
Purushottam Pandey1, Surbhi Bhatia Khan2,3,4, Jyoti Pruthi1
1Manav Rachna University (MRU), Faridabad, Haryana, India.
Frontiers in Medicine
|July 2, 2025
Summary
This study introduces an advanced AI model using deep learning for accurate Alzheimer's disease (AD) detection and progression prediction. The AI achieves high accuracy, aiding faster diagnosis and personalized treatment plans for AD.
Area of Science:
- Neuroscience
- Artificial Intelligence
- Medical Imaging Analysis
Background:
- Traditional Alzheimer's disease (AD) diagnosis is time-consuming and prone to errors.
- Existing methods struggle with large datasets, leading to slower and potentially inaccurate classifications.
- Advancements in AI, machine learning (ML), and deep learning (DL) offer potential solutions for improved AD detection.
Purpose of the Study:
- To enhance the accuracy and efficiency of Alzheimer's disease (AD) detection and classification.
- To develop an AI model capable of predicting AD progression.
- To integrate deep learning with brain simulation for deeper insights into AD mechanisms.
Main Methods:
- Utilized deep learning architectures, including ResNet101 with novel layers (PDPO, DCK) for feature extraction from ADNI and OASIS datasets.
- Employed Long Short-Term Memory (LSTM) networks for classifying individuals into cognitively normal (CN), mild cognitive impairment (MCI), and AD categories.
- Integrated Generative Adversarial Networks (GANs) to determine AD progression (progressive vs. non-progressive).
- Incorporated brain simulation models for visualizing and predicting AD evolution.
Main Results:
- Achieved high accuracy rates: 0.9931 on the ADNI dataset and 0.9985 on the OASIS dataset.
- The GAN model successfully identified the progressive nature of AD.
- The integrated approach offers a nuanced understanding of AD for personalized treatment.
Conclusions:
- The proposed AI framework significantly improves AD diagnosis accuracy and efficiency.
- This approach facilitates personalized treatment strategies by predicting disease progression.
- The integration of AI and brain simulation provides valuable insights into AD's neural mechanisms.
Keywords:
ADNIAlzheimer's diseaseOASIS datasetResNet101generative adversarial networklong short term memoryMore Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
678
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
678
Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265

